Introduction
B cell development is a highly regulated process that includes chain gene rearrangements (9) . Animals deficient for any component of the pre-BCR have a developmental block at the ordered rearrangement of Ig heavy and light chain genes (1). Formation and expression of a pre-BCR complex represthe pro-B to pre-B transition (10) (11) (12) (13) (14) (15) . CD79b is believed to be a signal transmitting subunit of the pre-BCR since it carries ents one requirement for B cell precursor maturation (2). The pre-BCR consists of a productive Ig heavy chain, V pre-B , λ5, an immunoreceptor tyrosine-based activation motif (ITAM) in its cytoplasmic domain (16) . In addition, we recently found CD79a (Igα) and CD79b (Igβ) (3,4), and elicits signals for several critical events. These include the transition of pro-B that even before the expression of Ig heavy chain, small amounts of CD79b were expressed on the surface of pro-B cells to pre-B cells (5), selective expansion of pre-B cells producing a productive Ig heavy chain (6,7), allelic exclusion cell lines and CD45R ϩ cells from recombination-activating gene (RAG)-2-deficient mice in a complex with calnexin (17) . of Ig heavy chain genes (8) and the promotion of light biotinylated anti-CD79b antibody for 5 min on ice. After if the pro-B cells in these animals could differentiate in response to CD79b cross-linking. Seven days after antibodyaddition of streptavidin (0.5 mg/ml), the cells were incubated at 37°C for various times. Stimulation was stopped by addition treatment, the expression of CD25, BP-1 and CD2 on CD45R ϩ cells was up-regulated, and expression of CD43 and λ5 was of cold inhibition buffer (10 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EGTA, 1.5 mM MgCl 2 , 100 mM NaF, 1 mM down-regulated in RAG2-KO mice ( Fig. 1A and B, upper panels) as we previously reported (17) . In addition, the Na 3 VO 4 , 1 µg/ml aprotinin, 1 µg/ml leupeptin, 10 µg/ml soybean trypsin inhibitor and 1 µg/ml α 1 -antitrypsin). Then proportion of small CD45R ϩ cells with a FCS value Ͻ70 was significantly increased (29-54%) after treatment (Fig. 1B ). cells were pelleted and lysed with lysis buffer (inhibition buffer containing 1% Nonidet P-40). Cellular proteins in the lysate These changes have been used to characterize events associated with the pro-B to pre-B transition (37, 38) . In contrast to were separated by SDS-PAGE and then transferred to PVDF membranes (Millipore, Bedford, MA). Membranes were RAG2-KO mice, their responses were significantly reduced in RAG2/BTK-DKO mice ( Fig. 1A and B, lower panels). Most blotted with 4G10 mAb and horseradish peroxidase (HRP)-conjugated anti-mouse IgG. For the detection of dramatically, the increase in CD25 ϩ cells almost completely disappeared (Fig. 1A ). CD79b stimulation also induced an tyrosine-phosphorylated BTK and PLC-γ2, lysates were immunoprecipitated with anti-BTK and anti-PLC-γ2 antibodies increase in absolute numbers of CD45R ϩ cells in bone marrow in RAG2-KO mice. However, in RAG2/BTK-DKO mice, the respectively, separated with SDS-PAGE, and transferred to PVDF membranes. The membranes were blotted with number of CD45R ϩ bone marrow cells did not change after CD79b stimulation (Fig. 1C) . To test the possibility that stronger anti-BTK551PY, anti-BTK223PY or 4G10 mAb followed by HRP-conjugated anti-mouse IgG antibody. For the detection CD79b stimulation is required for RAG2/BTK-DKO pro-B cells to differentiate into pre-B cells, we also tried 3.5 times higher of phosphorylated Erk, lysates were applied to SDS-PAGE and immunoblotted with anti-phosphorylated-Erk antibody in doses (700 µg/mouse i.v.) of anti-CD79b mAb (data not shown), but RAG2/BTK-DKO pro-B cells did not differentiate. combination with HRP-conjugated anti-rabbit IgG antibodies. All immunoblots were visualized by ECL reagent (Amersham We examined mice 4, 7, 11 and 14 days after anti-CD79b injection, but found no CD25 ϩ CD45R ϩ cells in RAG2/BTKPharmacia Biotech, Uppsala, Sweden). DKO mice (Fig. 2 ). These results demonstrate that RAG2/ T cell reconstitution BTK-DKO mice have impaired differentiation responses to anti-CD79b. For the T cell transfer experiment, lymph node cells were collected from 8-week-old C57BL/6 mice and 2ϫ10 7 
cells
The unresponsiveness of RAG2/BTK-DKO mice to anti-CD79b were injected i.v. into RAG2-KO or RAG2/BTK-DKO mice.
treatment is due to a defect in the CD79b signaling After 4 days of transfer, they were injected i.v. with 200 µg of Although the surface markers on pro-B cells were comparable anti-CD79b mAb. For the thymocyte transfer, 4ϫ10 7 thymobetween untreated RAG2/BTK-DKO and RAG2-KO mice cytes from 6-week-old C57BL/6 mice were injected i.v. and ( Fig. 1) , there was a possibility that RAG2/BTK-DKO mice anti-CD79b mAb was injected after 3 weeks. For the thymus might have a deficiency of CD79b-expressing cells. As CD79b transfer (35) , thymus lobes from 6-week-old C57BL/6 mice is too low to detect quantitatively on pro-B cells (17), we were implanted s.c. and anti-CD79b mAb was injected examined tyrosine phosphorylation of intracellular proteins 5 weeks later. All mice were sacrificed 6 days after injection after CD79b cross-linking in vitro. As previously described of anti-CD79b mAb and bone marrow cells were stained as (17) , rapid tyrosine phosphorylation of intracellular proteins above. Also, expression of CD3 on spleen cells or bone was induced in RAG2-KO bone marrow cells by anti-CD79b. marrow cells was analyzed with flow cytometry following Similar levels of tyrosine phosphorylation of intracellular prostaining with anti-CD3 mAb.
teins were induced in RAG2/BTK-DKO bone marrow cells ( pro-B cells. mice. This implies that BTK is dispensable for development of pro-B cells, although BTK is known to be expressed from Next, we evaluated particular intracellular signaling events an early stage (36) . This is consistent with a previous report after CD79b cross-linking of pro-B cells. First, we examined that BTK-deficient mice have normal numbers of pro-B cells whether BTK became phosphorylated on tyrosine by cross-(27).
linking CD79b on RAG2-KO pro-B cells. For this purpose, we utilized phosphopeptide-specific anti-BTK mAb. 223PY and RAG2/BTK-DKO mice are unresponsive to anti-CD79b 551PY antibodies specifically recognize BTK protein only treatment when its tyrosine residues at position 223 (autophosphorylation site) and position 551 (transphosphorylation site) are We next treated RAG2-KO and RAG2/BTK-DKO mice by i.v. injection with 200 µg of HM79 anti-CD79b mAb to determine phosphorylated (34,39). Purified CD45R ϩ cells were stimu- in Fig. 4(A) , most purified CD45R ϩ cells expressed BTK. Ramos human B cell line (34). Immunoblotting with the same mAb detected phosphorylated BTK (77 kDa), confirming the specificity of the mAb (Fig. 4B ). This result shows that BTK undergoes tyrosine phosphorylation after cross-linking CD79b and that BTK is directly activated downstream of CD79b signaling. able amounts of PLC-γ2 phosphorylation were also detected
Immunoprecipitants were subjected to immunoblotting with anti-PY551 (upper) or anti-PY223 (middle) BTK mAb. The total amount of in RAG2/BTK-DKO cells (Fig. 5A ). We could not observe co- (data not shown). Next, we examined the activation of Erk1/2 by phosphorylation. In contrast to BTK-deficient DT40 cells which have partial abrogation of Erk1/2 phosphorylation after BCR ligation (41), Erk1/2 were activated by CD79b After the stimulation with CD79b, the cross-linking, phosphocross-linking in RAG2/BTK-DKO cells as well as RAG2-KO Tyr223-BTK ϩ population increased from 5.6 to 24.7%. In cells (Fig. 5B) . Equal amounts of total Erk1/2 protein were the same stimulation, the phospho-Tyr551-BTK ϩ population verified by reprobing the membranes with anti-Erk1/2 antibody increased from 10.7 to 68.6%. These changes are comparable to the BTK phosphorylation induced by IgM cross-linking of (Fig. 5B, lower panel) . 
T cell reconstitution in RAG2/BTK-DKO mice does not restore
The that there could be CD79b-independent signals mediated expression (Table 1) . through a pre-BCR complex. CD79b cross-linking may deliver a BTK-dependent signal, whereas additional Ig heavy chainDiscussion dependent signals appear to compensate for a loss of function of BTK in mice. BTK is a tyrosine kinase required for B cell development.
Second, we must also consider the differentiation stages However, appropriate models were not available for investigarepresented by the stimulated cells. Pre-BCR complex is ting its importance at early stages of B cell development. We normally formed and expressed on large pre-B cells. In devised a unique differentiation system utilizing RAG/BTKcontrast, we stimulated CD79b in a complex with calnexin on DKO mice and found that BTK functions downstream of cells at the pro-B stage. This difference in maturation of the CD79b to induce the transition from the pro-B to the pre-B target cells might affect the extent of BTK dependency. stage. Anti-CD79b-induced differentiation of pro-B cells was Third, BTK might also transmit negative signals in early B greatly impaired in the absence of BTK, indicating that BTK lineage development. In several in vitro studies, XID B lineage is essential. This result is particularly impressive since XID and BTK-KO mice have normal numbers of pre-B cells (27).
cells have had an advantage over wild-type cells. One is the more rapid establishment of long-term bone marrow cultures molecules to the lipid raft and results in impaired differentiation signal transmission. from XID mice (44) and another is the high frequency of colony-forming units responsive to IL-7 (CFU-IL-7) in XID Our results, using RAG2/BTK-DKO mice and anti-CD79b administration, demonstrated the involvement of BTK in a bone marrow cells (45) . We also observed better expansion and production of cytoplasmic µ ϩ pre-B cells in stroma/ signaling pathway downstream of CD79b in the pre-BCR complex. This showed that the pro-B/pre-B transition is a serum-free cultures initiated with lineage marker (Lin) -c-kitbone marrow cells from XID mice as compared to controls critical target for BTK malfunction even in mice. Moreover, our system provides a potential way to identify target molec-(T. . Phosphorylation of these proteins by antiCD79b mAb treatment has been shown to be a specific effect of anti-CD79b mAb but not to be a non-specific effect of References hamster mAb by using control antibody (17) . Pre-BCR may have different or redundant signaling pathways leading to the 1 Alt, F. W., Yancopoulos, G. D., Blackwell, T. K., Wood, C., Thomas, E., Boss, M., Coffman, R., Rosenberg, N., Tonegawa, activation of PLC-γ2 and Erk1/2, although both pre-BCR PLC-γ2-independent pathway might be important also to the the absence of BTK causes defective recruitment of signaling
